FIELD: biotechnology.
SUBSTANCE: disclosed strain Levilactobacillu brevis “ВКШМ-Г-07ПД”, has antagonist activity with respect to antibiotic-resistant strains Salmonella Enteritidis and Salmonella Typhimurium. Strain exhibits high resistance to gastric and intestinal stress and effective adhesion to human Caco-2 enterocytes, porcine IPEC-J2 enterocytes and chicken CPCE enterocytes. Strain L. brevis “ВКШМ-Г-07ПД” is capable of self-aggregation and co-aggregation with pathogens S. Enteritidis and S. Typhimurium.
EFFECT: strain Levilactobacillu brevis “ВКШМ-Г-07ПД” can be used as a probiotic fodder additive to reduce the spread of salmonella infections among farm animals and reduce the possibility of transmitting these infections to humans.
1 cl, 5 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LACTOBACILLUS SALIVARIUS VKSHM-G-08PD STRAIN | 2024 |
|
RU2822455C1 |
| SALMONELLA ENTERICA BACTERIAL STRAIN VGNKI-11 (VKSHM-B-848M) AS CONTROL STRAIN FOR PHENOTYPIC AND MOLECULAR STUDIES IN DIAGNOSIS OF SALMONELLOSIS | 2020 |
|
RU2752895C1 |
| SALMONELLA INFANTIS BACTERIAL STRAIN USED AS A POSITIVE CONTROL FOR MOLECULAR GENETIC AND MICROBIOLOGICAL STUDIES RELATED TO THE DETERMINATION OF SENSITIVITY OF MICROORGANISMS TO ANTIBACTERIAL DRUGS | 2021 |
|
RU2782213C1 |
| POLYRESISTANT ESCHERICHIA COLI BACTERIAL STRAIN FOR DETERMINING THE BACTERICIDAL EFFECT OF ANTIBACTERIAL DRUGS IN VETERINARY MEDICINE | 2022 |
|
RU2797383C1 |
| ESCHERICHIA COLI С41 BACTERIAL STRAIN FOR OBTAINING A PROBIOTIC PREPARATION FOR THE PREVENTION OF COLIBACILLOSIS IN FARM ANIMALS | 2023 |
|
RU2807738C1 |
| ESCHERICHIA COLI Q5 BACTERIAL STRAIN, PROMISING FOR OBTAINING PROBIOTIC PREPARATION FOR PREVENTION OF COLIBACILLOSIS IN POULTRY | 2023 |
|
RU2806907C1 |
| SALMONELLA ENTERICA BACTERIAL STRAIN (VKSHM-B-849 M) AS A CONTROL STRAIN FOR MICROBIOLOGICAL AND MOLECULAR GENETIC STUDIES IN DETERMINING ANTIBIOTIC RESISTANCE | 2020 |
|
RU2759396C1 |
| METHOD FOR MOLECULAR GENETIC TYPING OF SALMONELLA STRAINS ON INDEL MARKERS | 2022 |
|
RU2786577C1 |
| BACTERIAL STRAIN BACILLUS TOYONENSIS VKPM B-13249, HAVING MARKED ANTAGONISM WITH RESPECT TO MICROORGANISMS ESCHERICHIA COLI, CANDIDA ALBICANS, STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS EPIDERMIDIS, SALMONELLA TYPHIMURIUM, SHIGELLA SONNEI, PSEUDOMONAS AERUGINOSA | 2018 |
|
RU2693439C1 |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INTESTINAL MUCOSA INFLAMMATORY DISEASES ON THE BASIS OF LACTOBACILLUS BREVIS 47f STRAIN, MANIFESTING A LOCAL ANTI-INFLAMMATORY ACTIVITY | 2018 |
|
RU2675110C1 |
